Dr. Chris S. Breivogel

Associate Professor
Pharmaceutical Sciences
Campbell University
United States of America

Biography

Dr. Chris S. Breivogel is an Associate professor in the deaprtment of Pharmaceutical sciences in Campbell University. He completed his BS Biochemistry with Distinction and Honors, Phi Beta Kappa in the Department of Chemistry from University of North Carolina at Chapel Hill, Chapel Hill, NC in 1987-1992. He did UNC Study Abroad program, Georg-August-Universitaet, Goettingen in Germany, 1989-1990. He obtained his PhD in Pharmacology from Wake Forest University School of Medicine, Winston-Salem, NC, 1994-1998. He is a Post-doctoral trainee, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 1999-2000. He pUblished many articles in the Pharmaceutical sciences.

Research Intrest

Synthetic cannabinoids, G-protein coupled receptor signaling,Marijuana

List of Publications
Breivogel CS, Vaghela MS. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice. Journal of Receptors and Signal Transduction. 2015 Jan 2;35(1):98-106.
Breivogel C, Jamerson B. Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats. Pharmaceutical biology. 2012 Oct 1;50(10):1310-6.
Breivogel CS, Sim-Selley LJ. Basic neuroanatomy and neuropharmacology of cannabinoids. International Review of Psychiatry. 2009 Jan 1;21(2):113-21.

Global Scientific Words in Pharmaceutical Sciences